KIR matching in hematopoietic stem cell transplantation

Current Opinion in Immunology

Volumn 17, Issue 5, 2005, Pages 553-559

  Bignon, Jean Denis ^a   Gagne, Katia ^a  

^a ETABLISSEMENT FRANÇAIS DU SANG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; RECEPTOR; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ALLOIMMUNITY; ANTIGEN SPECIFICITY; GENE EXPRESSION; GRAFT VERSUS HOST REACTION; HAPLOTYPE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA MATCHING; HUMAN; NATURAL KILLER CELL; REVIEW; T CELL DEPLETION; T LYMPHOCYTE;

ANIMALS; GRAFT REJECTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; KILLER CELLS, NATURAL; RECEPTORS, IMMUNOLOGIC;

EID: 23944486999     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coi.2005.07.014     Document Type: Review

References (52)

1. R. Jacobs, M. Stoll, G. Stratmann, R. Leo, H. Link, and R.E. Schmidt CD16- CD56+ natural killer cells after bone marrow transplantation Blood 79 1992 3239 3244
2. A. Charbonnier, D. Sainty, C. Faucher, C. Arnoulet, C. Chabannon, and D. Blaise Immune reconstitution after blood cell transplantation Hematol Cell Ther 39 1997 261 264
3. L. Ruggeri, M. Capanni, E. Urbani, K. Perruccio, W.D. Shlomchik, A. Tosti, S. Posati, D. Rogaia, F. Frassoni, and F. Aversa Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants Science 295 2002 2097 2100
4. I. Barao, and W. Murphy The immunobiology of natural killer cells and bone marrow allograft rejection Biol Blood Marrow Transplant 9 2003 727 741
5. L. Moretta, C. Bottino, G. Ferlazzo, D. Pende, G. Melioli, M.C. Mingari, and A. Moretta Surface receptors and functional interactions of human natural killer cells: from bench to the clinic Cell Mol Life Sci 60 2003 2139 2146
6. D. Middleton, M. Curran, and L. Maxwell Natural killer cells and their receptors Transpl Immunol 10 2002 147 164
7. K.C. Hsu, X. Liu, A. Selvakumar, E. Mickelson, R.J. O'Reilly, and B. Dupont Killer Ig-like receptor haplotype analysis by gene content: evidence for genomic diversity with a minimum of six basic framework haplotypes, each with multiple subsets J Immunol 169 2002 5118 5129
8. P. Parham Immunogenetics of killer cell immunoglobulin-like receptors Mol Immunol 42 2005 459 462
9. M. Colonna, E. Brooks, M. Falco, G.B. Ferrara, and J.L. Strominger Generation of allospecific natural killer cells by stimulation across a polymorphism of HLA-C Science 260 1993 1121 1124
10. P. Parham, and K. McQueen Alloreactive killer cells: hindrance and help for haematopoietic transplants Nat Rev Immunol 3 2003 108 122
11. N.M. Valiante, M. Uhrberg, H.G. Shilling, K. Lienert-Weidenbach, K.L. Arnett, A. D'Andrea, J.H. Phillips, L.L. Lanier, and P. Parham Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors Immunity 7 1997 739 751
12. T. Sasazuki, T. Juji, Y. Morishima, N. Kinukawa, H. Kashiwabara, H. Inoko, T. Yoshida, A. Kimura, T. Akaza, and N. Kamikawaji Effect of matching of class I HLA alleles on clinical outcome after transplantation of hematopoietic stem cells from an unrelated donor N Engl J Med 339 1998 1177 1185
13. E.W. Petersdorf, C. Anasetti, P. Martin, T. Gooley, J. Radich, M. Malkki, A. Woolfrey, A. Smith, E. Mickelson, and J.A. Hansen Limits of HLA mismatching in unrelated hematopoietic cell transplantation Blood 104 2004 2976 2980
14. A. Bishara, A. Amar, C. Brautbar, R. Condiotti, V. Lazarovitz, and A. Nagler The putative role of HLA-C recognition in graft versus host disease (GVHD) and graft rejection after unrelated bone marrow transplantation (BMT) Exp Hematol 23 1995 1667 1675
15. E.W. Petersdorf, G. Longton, C. Anasetti, P.J. Martin, E.M. Mickelson, A.G. Smith, and J.A. Hansen The significance of HLA-DRB1 matching on clinical outcome after HLA-A, B, DR identical unrelated donor marrow transplantation Blood 86 1995 1606 1613
16. A. Nagler, C. Brautmar, S. Slavin, and A. Bishara Bone marrow transplantation using unrelated and family related donors: the impact of HLA-C disparity Bone Marrow Transplant 18 1996 891 897
17. E.W. Petersdorf, C. Kollman, C.K. Hurley, B. Dupont, A. Nademanee, A.B. Begovich, D. Weisdorf, and P. McGlave Effect of HLA class II gene disparity on clinical outcome in unrelated donor hematopoietic cell transplantation for chronic myeloid leukemia: the US National Marrow Donor Program Experience Blood 98 2001 2922 2929
18. Y. Morishima, T. Sasazuki, H. Inoko, T. Juji, T. Akaza, K. Yamamoto, Y. Ishikawa, S. Kato, H. Sao, and H. Sakamaki The clinical significance of human leukocyte antigen (HLA) allele compatibility in patients receiving a marrow transplant from serologically HLA-A, HLA-B, and HLA-DR matched unrelated donors Blood 99 2002 4200 4206
19. M. Schaffer, A. Aldener-Cannava, M. Remberger, O. Ringden, and O. Olerup Roles of HLA-B, HLA-C and HLA-DPA1 incompatibilities in the outcome of unrelated stem-cell transplantation Tissue Antigens 62 2003 243 250
20. N. Flomenberg, L. Baxter-Lowe, D. Confer, M. Fernandez-Vina, A. Filipovich, M. Horowitz, C. Hurley, C. Kollman, C. Anasetti, and H. Noreen Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome Blood 104 2004 1923 1930
21. J. v Rood HLA-C alleles can no longer be ignored in bone marrow donor selection Blood 104 2004 1912 1913
22. K. Karre A perfect mismatch Science 295 2002 2029 2031
23. D.W. Beelen, H. Ottinger, S. Ferencik, A.H. Elmaagacli, R. Peceny, R. Trenschel, and H. Grosse-Wilde Genotypic inhibitory killer immunoglobulin-like receptor ligand incompatibility enhances the long-term antileukemic effect of unmodified allogeneic hematopoietic stem cell transplantation in patients with myeloid leukemias Blood 105 2005 2594 2600
24. K.C. Hsu, C. Keever-Taylor, A. Wilton, C. Pinto, G. Heller, K. Arkun, R.J. O'reilly, M.M. Horowitz, and B. Dupont Improved outcome in HLA-identical sibling hematopoietic stem cell transplantation for acute myelogenous leukemia (AML) predicted by KIR and HLA genotypes Blood 105 2005 4878 4884 One of the most recent papers on KIR-driven alloreactivity in HSCT considering KIR genotype in addition to the HLA genotype of the recipient. This paper reveals that 'missing KIR ligand' in the recipient can be commonly found in allotransplantation, occurring not only in HLA-identical transplants, but also in HLA-identical sibling transplants.
25. K. Gagne, G. Brizard, B. Gueglio, N. Milpied, P. Herry, F. Bonneville, M.L. Cheneau, N. Schleinitz, A. Cesbron, and G. Follea Relevance of KIR gene polymorphisms in bone marrow transplantation outcome Hum Immunol 63 2002 271 280
26. S.M. Davies, L. Ruggieri, T. DeFor, J.E. Wagner, D.J. Weisdorf, J.S. Miller, A. Velardi, and B.R. Blazar Evaluation of KIR ligand incompatibility in mismatched unrelated donor hematopoietic transplants. Killer immunoglobulin-like receptor Blood 100 2002 3825 3827
27. S. Giebel, F. Locatelli, T. Lamparelli, A. Velardi, S. Davies, G. Frumento, R. Maccario, F. Bonetti, J. Wojnar, and M. Martinetti Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors Blood 102 2003 814 819
28. M. Bornhauser, R. Schwerdtfeger, H. Martin, K.H. Frank, C. Theuser, and G. Ehninger Role of KIR ligand incompatibility in hematopoietic stem cell transplantation using unrelated donors Blood 103 2004 2860 2861
29. A. Bishara, D. De Santis, C.C. Witt, C. Brautbar, F.T. Christiansen, R. Or, A. Nagler, and S. Slavin The beneficial role of inhibitory KIR genes of HLA class I NK epitopes in haploidentically mismatched stem cell allografts may be masked by residual donor-alloreactive T cells causing GVHD Tissue Antigens 63 2004 204 211
30. M.A. Cook, D. Millingan, C.D. Fegan, P.J. Darbyshire, P. Mahendra, C.F. Craddock, P.A. Moss, and D.C. Briggs The impact of donor KIR and patient HLA-C genotypes on outcome following HLA-identical sibling hematopoietic stem cell transplantation for myeloid leukemia Blood 103 2004 1521 1526
31. M. Schaffer, K. Malmberg, O. Ringden, H.G. Ljunggren, and M. Remberger Increased infection-related mortality in KIR-ligand-mismatched unrelated allogeneic hematopoietic stem-cell transplantation Transplantation 78 2004 1081 1085
32. W.I. Bensinger, and H. Deeg Blood or marrow? Lancet 355 2000 1199 1200
33. M. Korbling, and P. Anderlini Peripheral blood stem cell versus bone marrow allotransplantation: does the source of hematopoietic stem cells matter? Blood 98 2001 2900 2908
34. O. Asai, D. Longo, Z.G. Tian, R.L. Hornung, D.D. Taub, F.W. Ruscetti, and W.J. Murphy Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation J Clin Invest 101 1998 1835 1842
35. L. Weiss, A. Abdul-Hai, Y. Shufaro, S. Reich, and S. Slavin Linomide administration following bone marrow transplantation in mice Cancer Immunol Immunother 51 2002 596 602
36. K.J. Malmberg, M. Schaffer, O. Ringden, M. Remberger, and H.G. Ljunggren KIR-ligand mismatch in allogeneic hematopoietic stem cell transplantation Mol Immunol 42 2005 531 534
37. M. Uhrberg, N. Valiante, B.P. Shum, H.G. Shilling, K. Lienert-Weidenbach, B. Corliss, D. Tyan, L.L. Lanier, and P. Parham Human diversity in killer cell inhibitory receptor genes Immunity 7 1997 753 763
38. M. Yawata, N. Yawata, K.L. McQueen, N.W. Cheng, L.A. Guethlein, R. Rajalingam, H.G. Shilling, and P. Parham Predominance of group A KIR haplotypes in Japanese associated with diverse NK cell repertoires of KIR expression Immunogenetics 54 2002 543 550
39. B. Dupont, and K. Hsu Inhibitory killer Ig-like receptor genes and human leukocyte antigen class I ligands in haematopoietic stem cell transplantation Curr Opin Immunol 16 2004 634 643
40. H.G. Shilling, N. Young, L.A. Guethlein, N.W. Cheng, C.M. Gardiner, D. Tyan, and P. Parham Genetic control of human NK cell repertoire J Immunol 169 2002 239 247
41. J.E. Gumperz, N. Valiante, P. Parham, L.L. Lanier, and D. Tyan Heterogeneous phenotypes of expression of the NKB1 natural killer cell class I receptor among individuals of different human histocompatibility leukocyte antigens types appear genetically regulated, but not linked to major histocompatibililty complex haplotype J Exp Med 183 1996 1817 1827
42. C. Frohn, P. Schlenke, and H. Kirchner The repertoire of HLA-Cw-specific NK cell receptors CD158 a/b (EB6 and GL183) in individuals with different HLA phenotypes Immunology 92 1997 567 570
43. C.M. Gardiner, L. Guethlein, H.G. Shilling, M. Pando, W.H. Carr, R. Rajalingam, C. Vilches, and P. Parham Different NK cell surface phenotypes defined by the DX9 antibody are due to KIR3DL1 gene polymorphism J Immunol 166 2001 2992 3001
44. C. Vilches, and P. Parham KIR: diverse, rapidly evolving receptors of innate and adaptive immunity Annu Rev Immunol 20 2002 217 251
45. W. Leung, R. Iyengar, V. Turner, P. Lang, P. Bader, P. Conn, D. Niethammer, and R. Handgretinger Determinants of antileukemia effects of allogeneic NK cells J Immunol 172 2004 644 650 This work provides additional fundamental insights into the anti-leukemia response of allogeneic NK cells. The authors studied the characteristics of donor NK cells, recipient leukemia cells and the cytokine environment.
46. H.G. Shilling, K. McQueen, N.W. Cheng, J.A. Shizuru, R.S. Negrin, and P. Parham Reconstitution of NK cell receptor repertoire following HLA-matched hematopoietic cell transplantation Blood 101 2003 3730 3740
47. L. Denis, K. Gagne, B. Gueglio, N. Kerdudou, N. Milpied, P. Simon, G. Follea, M. Bonneville, J.L. Harousseau, and J.D. Bignon NK-KIR transcript kinetics correlate with acute Graft-versus-Host-Disease occurrence following Allogeneic Bone Marrow Transplantation Hum Immunol 66 2005 447 459
48. C.A. Garcia, J. Robinson, L.A. Guethlein, P. Parham, J.A. Madrigal, and S.G. Marsh Human KIR sequences Immunogenetics 55 2003 227 239
49. S.G. Marsh, P. Parham, B. Dupont, D.E. Geraghty, J. Trowsdale, D. Middleton, C. Vilches, M. Carrington, C. Witt, and L.A. Guethlein Killer-cell immunoglobulin-like receptor (KIR) nomenclature report Hum Immunol 64 2003 648 654
50. M.J. Pando, C. Gardiner, M. Gleimer, K.L. McQueen, and P. Parham The protein made from a common allele of KIR3DL1 (3DL1*004) is poorly expressed at cell surfaces due to substitution at positions 86 in Ig domain 0 and 182 in Ig domain 1 J Immunol 171 2003 6640 6649
51. L. Ruggeri, M. Capanni, A. Mancusi, F. Aversa, M.F. Martelli, and A. Velardi Natural killer cells as a therapeutic tool in mismatched transplantation Best Pract Res Clin Haematol 17 2004 427 438 This paper describes donor-versus-recipient NK cell alloreactivity in haploidentical transplants and how to search for NK alloreactive donors.
52. J.R. Passweg, M. Stern, U. Koehl, L. Uharek, and A. Tichelli Use of natural killer cells in hematopoetic stem cell transplantation Bone Marrow Transplant 35 2005 637 643